231 related articles for article (PubMed ID: 23091058)
1. Network reconstruction and systems analysis of cardiac myocyte hypertrophy signaling.
Ryall KA; Holland DO; Delaney KA; Kraeutler MJ; Parker AJ; Saucerman JJ
J Biol Chem; 2012 Dec; 287(50):42259-68. PubMed ID: 23091058
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.
Ryall KA; Bezzerides VJ; Rosenzweig A; Saucerman JJ
J Mol Cell Cardiol; 2014 Jul; 72():74-84. PubMed ID: 24613264
[TBL] [Abstract][Full Text] [Related]
3. Automated image analysis identifies signaling pathways regulating distinct signatures of cardiac myocyte hypertrophy.
Bass GT; Ryall KA; Katikapalli A; Taylor BE; Dang ST; Acton ST; Saucerman JJ
J Mol Cell Cardiol; 2012 May; 52(5):923-30. PubMed ID: 22142594
[TBL] [Abstract][Full Text] [Related]
4. Context-specific network modeling identifies new crosstalk in β-adrenergic cardiac hypertrophy.
Khalilimeybodi A; Paap AM; Christiansen SLM; Saucerman JJ
PLoS Comput Biol; 2020 Dec; 16(12):e1008490. PubMed ID: 33338038
[TBL] [Abstract][Full Text] [Related]
5. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling.
Pare GC; Bauman AL; McHenry M; Michel JJ; Dodge-Kafka KL; Kapiloff MS
J Cell Sci; 2005 Dec; 118(Pt 23):5637-46. PubMed ID: 16306226
[TBL] [Abstract][Full Text] [Related]
6. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
7. GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy.
Duran J; Oyarce C; Pavez M; Valladares D; Basualto-Alarcon C; Lagos D; Barrientos G; Troncoso MF; Ibarra C; Estrada M
PLoS One; 2016; 11(12):e0168255. PubMed ID: 27977752
[TBL] [Abstract][Full Text] [Related]
8. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
Li J; Kritzer MD; Michel JJ; Le A; Thakur H; Gayanilo M; Passariello CL; Negro A; Danial JB; Oskouei B; Sanders M; Hare JM; Hanauer A; Dodge-Kafka K; Kapiloff MS
Circ Res; 2013 Jan; 112(1):128-39. PubMed ID: 22997248
[TBL] [Abstract][Full Text] [Related]
9. The mAKAP signalosome and cardiac myocyte hypertrophy.
Bauman AL; Michel JJ; Henson E; Dodge-Kafka KL; Kapiloff MS
IUBMB Life; 2007 Mar; 59(3):163-9. PubMed ID: 17487687
[TBL] [Abstract][Full Text] [Related]
10. mAKAP-a master scaffold for cardiac remodeling.
Passariello CL; Li J; Dodge-Kafka K; Kapiloff MS
J Cardiovasc Pharmacol; 2015 Mar; 65(3):218-25. PubMed ID: 25551320
[TBL] [Abstract][Full Text] [Related]
11. Calcium-dependent gene regulation in myocyte hypertrophy and remodeling.
Williams RS; Rosenberg P
Cold Spring Harb Symp Quant Biol; 2002; 67():339-44. PubMed ID: 12858558
[No Abstract] [Full Text] [Related]
12. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
Liu L; Zhao X; Pierre SV; Askari A
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1489-97. PubMed ID: 17728397
[TBL] [Abstract][Full Text] [Related]
13. Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo.
Ha T; Hua F; Li Y; Ma J; Gao X; Kelley J; Zhao A; Haddad GE; Williams DL; Browder IW; Kao RL; Li C
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H985-94. PubMed ID: 16199478
[TBL] [Abstract][Full Text] [Related]
14. Myocyte-Derived Hsp90 Modulates Collagen Upregulation via Biphasic Activation of STAT-3 in Fibroblasts during Cardiac Hypertrophy.
Datta R; Bansal T; Rana S; Datta K; Datta Chaudhuri R; Chawla-Sarkar M; Sarkar S
Mol Cell Biol; 2017 Mar; 37(6):. PubMed ID: 28031326
[TBL] [Abstract][Full Text] [Related]
15. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
16. MG53, A Novel Regulator of KChIP2 and I
Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophy.
Heineke J; Kempf T; Kraft T; Hilfiker A; Morawietz H; Scheubel RJ; Caroni P; Lohmann SM; Drexler H; Wollert KC
Circulation; 2003 Mar; 107(10):1424-32. PubMed ID: 12642365
[TBL] [Abstract][Full Text] [Related]
18. Temporal dynamics of cardiac hypertrophic growth in response to pressure overload.
Wang Y; Zhang Y; Ding G; May HI; Xu J; Gillette TG; Wang H; Wang ZV
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1119-H1129. PubMed ID: 28822967
[TBL] [Abstract][Full Text] [Related]
19. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
20. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]